BridgeMD
New treatment option for Intra-articular Fracture of the Mandibular Condyle
Official title Treatment of Intra-articular Fractures of the Mandibular Condyle
ClinicalTrials.gov ID: NCT04776473
What this study is testing
- What it's testing
- Intra-articular fractures of the mandibular condyle ((IAFC) are usually treated by means of physical therapy with or without transient maxillo-mandibular fixation (conservative or closed treatment). However, this can lead to incomplete manducatory function recovery due to limited mandibular mobility.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 84
You may be able to join if
- Adult (≥18 y-o) \< 85 years
- Displaced non-comminuted intra-articular fracture of the mandibular condyle (IAFC) as defined by a fracture line above a horizontal line tangent to...
- Objectifiable induced malocclusion and/or ramus shortening ≥2 mm on CT-scan (a ramus shortening ≥2 mm on CT-scan is necessary in case of other...
- Unilateral or bilateral fracture
- Isolated or associated with other facial / extra-facial skeleton / dental / soft tissue lesions
You likely can't join if
- Contraindication to surgical treatment (for any medical or anatomical reason, like comminuted fracture for instance)
- Major teeth loss or edentulous patient (occlusion impossible to assess)
- History of mandibular fracture
- History of temporo-mandibular joint (TMJ) disorder
- Dentofacial dysmorphosis causing significant malocclusion
- Predictable inability to comply with the follow-up
See the full eligibility criteria
- Adult (≥18 y-o) \< 85 years
- Displaced non-comminuted intra-articular fracture of the mandibular condyle (IAFC) as defined by a fracture line above a horizontal line tangent to the mandibular notch
- Objectifiable induced malocclusion and/or ramus shortening ≥2 mm on CT-scan (a ramus shortening ≥2 mm on CT-scan is necessary in case of other associated mandibular or occluso-facial fractures)
- Unilateral or bilateral fracture
- Isolated or associated with other facial / extra-facial skeleton / dental / soft tissue lesions
- Treatment within 14 days post trauma
- Affiliation to a social security regime (excepted AME)
- Written informed consent
- Contraindication to surgical treatment (for any medical or anatomical reason, like comminuted fracture for instance)
- Major teeth loss or edentulous patient (occlusion impossible to assess)
- History of mandibular fracture
- History of temporo-mandibular joint (TMJ) disorder
- Dentofacial dysmorphosis causing significant malocclusion
- Predictable inability to comply with the follow-up
- Unconsciousness / severe polytrauma
- Participation in another treatment study
The study team makes the final eligibility decision.
Where it's taking place
- Angers, France
- Annecy, France
- Marseille, France
- Nantes, France
- Paris, France
- Strasbourg, France
- Toulouse, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 84 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Angers, France; Annecy, France; Marseille, France; Nantes, France; Paris, France; Strasbourg, France and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.